Uhlmann Price Securities, LLC Tekla Life Sciences Investors Transaction History
Uhlmann Price Securities, LLC
- $169 Billion
- Q4 2025
A detailed history of Uhlmann Price Securities, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Uhlmann Price Securities, LLC holds 76,138 shares of HQL stock, worth $1.27 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
76,138
Previous 73,900
3.03%
Holding current value
$1.27 Million
Previous $1.15 Billion
11.46%
% of portfolio
0.76%
Previous 0.7%
Shares
6 transactions
Others Institutions Holding HQL
# of Institutions
89Shares Held
9.42MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.59MShares$43.1 Million1.2% of portfolio
-
Morgan Stanley New York, NY871KShares$14.5 Million0.0% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.2 Million0.16% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL423KShares$7.04 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY403KShares$6.72 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...